By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


OncoSec Medical Inc. 

200 South Virginia Street
8th Floor
Reno  Nevada  89501  U.S.A.
Phone: 775-562-0504 Fax: n/a


Medical Device

Company News
OncoSec Medical Inc. Announces New Phase II Trial In Head And Neck Cancer Using ImmunoPulse 12/9/2014 2:14:51 PM
OncoSec Medical Inc. Announces First Quarter Results For Fiscal Year End 2015 12/8/2014 11:21:50 AM
OncoSec Medical Inc. Reports Positive Top-Line Six-Month Primary Endpoint Data From Phase II Melanoma Trial Of ImmunoPulse Monotherapy 12/5/2014 12:10:31 PM
OncoSec Medical Inc. To Host Corporate Update Conference Call On December 9, 2014 12/5/2014 10:59:32 AM
OncoSec Medical Inc. Says ImmunoPulse Tumor Drug Met Phase II Endpoints 12/5/2014 10:36:30 AM
OncoSec Medical Inc. Reports ImmunoPulse May Prolong Survival Based On Analysis Of Long-Term Survival Data From Phase I Study In Melanoma 12/5/2014 9:36:50 AM
OncoSec Medical Inc. Collaborates With PerkinElmer, Inc. (PKI) And University of California, Los Angeles (UCLA) To Evaluate Patient-Selection Biomarker In Immunotherapy 12/2/2014 11:52:57 AM
OncoSec Medical Inc. To Present At Two Events In December 12/1/2014 3:01:48 PM
Nature Publication Co-Authored By Robert H. Pierce, Chief Scientific Officer, OncoSec Medical Inc. 12/1/2014 12:39:07 PM
University of California, San Francisco (UCSF) And OncoSec Medical Inc. Collaborate To Evaluate Investigational Combination Of ImmunoPulse And Anti-PD-1 Treatment 11/25/2014 10:36:55 AM